An FDA-approved neurotoxin for natural-looking wrinkle reduction.
Dysport (abobotulinumtoxinA) is an FDA-approved prescription injection for the temporary improvement of moderate to severe frown lines between the eyebrows (glabellar lines). Manufactured by Galderma, Dysport has been used in 69 countries worldwide.
Dysport works similarly to Botox by blocking nerve signals to muscles, but has a slightly different molecular structure that may spread more easily in the treatment area, which can be advantageous for larger treatment zones.
| Feature | Dysport | Botox |
|---|---|---|
| Active Ingredient | AbobotulinumtoxinA | OnabotulinumtoxinA |
| Onset | 2-3 days | 3-5 days |
| Duration | 3-4 months | 3-4 months |
| Spread | Wider diffusion | More localized |
Countries
Onset Time
Duration
Approved
Locate a trained practitioner experienced with Dysport treatments.
Find a Provider